Chiropractor Evansville Shares Perspective on the Role and Structure of Modern Chiropractic Services

January 10, 2026 - PRESSADVANTAGE - Chiropractor Evansville has released an announcement outlining its approach to ...

Immune system plays a major role in brain damage after repeated concussions, study suggests

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...
The Manila Times

Citrus Burn Examined (URGENT REPORT) The Science Behind the Orange Peel Trick for Metabolic Support

A commonly discussed concept in CitrusBurn reviews and consumer feedback is the idea of "clean energy.” This term is often ...
News-Medical.Net

Trial evaluates a traditional Chinese herbal formula for diabetic kidney disease with macroalbuminuria

Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...
Pharmabiz

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...
EurekAlert!

Ancient medicine meets modern trials in diabetic kidney disease care

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...
Seeking Alpha

FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of hematopoietic ...
Nasdaq

Omeros Wins FDA Approval For YARTEMLEA In Transplant-Associated Thrombotic Microangiopathy

(RTTNews) - Omeros Corporation (OMER) today announced that the FDA has approved YARTEMLEA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy in adults and ...
MarketWatch

Omeros Gets FDA Approval of Yartemlea

Omeros has won U.S. Food and Drug Administration approval of its Yartemlea treatment for an often-fatal complication of stem-cell transplants. Omeros on Wednesday said the approval covers Yartemlea ...
Times Argus

FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of hematopoietic stem cell ...
grafa

Omeros surges as FDA clears Yartemlea as first-ever stem cell complication therapy

Omeros Corporation (NASDAQ:OMER) said the U.S. Food and Drug Administration approved YARTEMLEA (narsoplimab-wuug) to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy, ...
IEEE

C²Former: Calibrated and Complementary Transformer for RGB-Infrared Object Detection

Abstract: Object detection on visible (RGB) and infrared (IR) images, as an emerging solution to facilitate robust detection for around-the-clock applications, has received extensive attention in ...